This is a public webinar discussing the world's first precision medicine program in ALS. It will include a presentation from our chief scientific officer and CEO, Steve Perrin, Ph.D. who will show data and discuss findings to date. Discussion will be a key part of this presentation. More than 250 people are enrolled in this program - thank you to all of them! We are excited to show you early data from this program as part of our commitment to efficiency, transparency and innovation as we discovery and develop effective treatments and cures for ALS. |